Inmune Bio (INMB) EPS (Diluted) (2021 - 2026)
Inmune Bio (INMB) EPS (Diluted) (2021 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Diluted) (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 137.11 Bn | 129.26 Bn | 2.84 Bn | 4.31 |
| 2 | Regeneron Pharmaceuticals | 84.98 Bn | 76.99 Bn | 3.93 Bn | 12.23 |
| 3 | Argenx Se | 64.52 Bn | 59.33 Bn | 1.37 Bn | 7.33 |
| 4 | Moderna | 53.23 Bn | 48.09 Bn | 52.00 Mn | -1.96 |
| 5 | BeOne Medicines | 41.23 Bn | 36.14 Bn | 1.53 Bn | 2.05 |
| 6 | Alnylam Pharmaceuticals | 30.65 Bn | 27.34 Bn | 992.69 Mn | 1.19 |
| 7 | Insmed | 27.15 Bn | 25.99 Bn | 358.27 Mn | -0.06 |
| 8 | Royalty Pharma | 26.98 Bn | 26.14 Bn | - | 0.15 |
| 9 | BioNTech SE | 26.78 Bn | 8.39 Bn | 668.28 Mn | -0.72 |
| 10 | Inmune Bio | 58.11 Mn | 39.70 Mn | - | -0.06 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -0.12 |
| Mar 31, 2026 | -0.23 |
| Dec 31, 2025 | -0.24 |
| Sep 30, 2025 | -0.32 |
| Jun 30, 2025 | -1.06 |
| Mar 31, 2025 | -0.86 |
| Dec 31, 2024 | -0.53 |
| Sep 30, 2024 | -7.79 |
| Jun 30, 2024 | -1.06 |
| Mar 31, 2024 | -1.93 |
| Dec 31, 2023 | -0.52 |
| Sep 30, 2023 | -0.75 |
| Jun 30, 2023 | -0.39 |
| Mar 31, 2023 | -0.39 |
| Dec 31, 2022 | -0.36 |
| Sep 30, 2022 | -29.67 |
| Jun 30, 2022 | -0.38 |
| Mar 31, 2022 | -0.39 |
| Dec 31, 2021 | -0.59 |
| Sep 30, 2021 | -3.13 |